A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer
Titel:
A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer
Auteur:
Paridaens, R. Van Aelst, F. Georgoulias, V. Samonnig, H. Cocquyt, V. Zielinski, C. Hausmaninger, H. Willemse, P. Boudraa, Y. Wildiers, J. Ramazeilles, C. Azli, N.